欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/6040/001
药品名称Ibuprofen Kabi 400 mg Infusionslösung
活性成分
    • ibuprofen 4.0 mg/ml
剂型Solution for infusion
上市许可持有人Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1 61352 Bad Homburg v.d.H. Germany
参考成员国 - 产品名称Germany (DE)
Ibuprofen Kabi 400 mg Infusionslösung
互认成员国 - 产品名称
    • Belgium (BE)
      Ibuprofen Fresenius Kabi 400 mg oplossing voor infusie
    • Netherlands (NL)
      Ibuprofen Fresenius Kabi 400 mg oplossing voor infusie
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Poland (PL)
      Ibuprofen Kabi
    • Hungary (HU)
    • Czechia (CZ)
      Ibuprofen Kabi
    • Romania (RO)
      Ibuprofen Kabi 400 mg soluţie perfuzabilă
    • Slovakia (SK)
      Ibuprofen Kabi 400 mg
    • Slovenia (SI)
许可日期2020/10/15
最近更新日期2024/10/25
药物ATC编码
    • M01AE01 ibuprofen
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase